The natural heterogeneity of Trypanosoma cruzi: biological and medical implications.
about
A simple strain typing assay for Trypanosoma cruzi: discrimination of major evolutionary lineages from a single amplification productPathogenesis of chagas' disease: parasite persistence and autoimmunityTwo approaches to discovering and developing new drugs for Chagas disease.Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.Trypanosoma cruzi in the chicken model: Chagas-like heart disease in the absence of parasitism.Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatmentA genomic scale map of genetic diversity in Trypanosoma cruzi.Two hybridization events define the population structure of Trypanosoma cruzi.Genomic variation of Trypanosoma cruzi: involvement of multicopy genesNatural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure.Evolution and pathology in chagas disease--a review.Selective binding of Trypanosoma cruzi to host cell membrane polypeptidesFlow cytometric analysis of the DNA synthetic cycle of Candida speciesVariation in antigenic determinants specific to the infective stage of Trypanosoma cruziNitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development.ISOZYME VARIABILITY IN TRYPANOSOMA CRUZI, THE AGENT OF CHAGAS' DISEASE: GENETICAL, TAXONOMICAL, AND EPIDEMIOLOGICAL SIGNIFICANCE.Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs.Potential Role of Carvedilol in the Cardiac Immune Response Induced by Experimental Infection with Trypanosoma cruziCyclic AMP-dependent protein kinase activity in Trypanosoma cruzi.The karyotype and ploidy of Trypanosoma cruziTrypanosoma cruzi: cell biological behavior of epimastigote and amastigote forms in axenic culture.Trypanosoma cruzi: analysis of the population dynamics of heterogeneous mixtures.Detection of antibodies in sera from Chagas' disease patients using a Trypanosoma cruzi immunodominant recombinant antigen.Trypanosoma cruzi: expression of antigenic component 5 among 35 laboratory clones obtained from 18 different isozymic variants.
P2860
Q28481698-3DFAD42B-BA1B-46FA-A0F4-2D4D5C0A3E18Q28742827-D1B1226E-458E-4D01-9E92-A86521881C06Q33503274-7786F02A-C8C5-4440-BE06-DB1CD9DC3EAFQ33604028-BC5337F1-19AB-43F2-810E-66C9158132B7Q33863596-DC33D5B7-16E6-414D-AF35-3243DC438CBCQ33962768-A95E63BB-5F35-4F61-BCF9-20B3D0147638Q34523989-B6DE2EB3-154E-49A4-9996-4F0327367BF4Q34589620-15BAF9B8-005B-4ADB-AF30-6C1A1B257AD0Q35105636-3B028095-859D-4F75-A3B0-FCE5C71BF343Q35584214-FB179198-2AAF-44E8-B3D4-76CFDD848FCDQ36637937-7DDCC28C-FF9C-4FDA-BC0C-C5491F60C41DQ36975123-7C9F6010-E181-4E6B-9AF0-28107FB7255CQ37020147-16D5F4A3-D26A-48FB-B2E6-8AB296E45419Q37026327-9D7AF2F0-ABAC-414A-B89E-60E184A2F1BDQ37732551-173773EA-5C9B-481E-A422-C76A735A2B45Q38752055-131D72B5-37A4-43DA-809B-52802B2490DCQ39701339-345A67D5-D41B-462A-B6B3-FDAACE58C044Q42102813-726CC513-595A-46FD-BAE8-DB16E63CFB96Q42125447-CA18D572-7287-43F6-9322-0D528E6F146DQ42569778-1E999F47-2A4E-483F-A6C5-A5DD42BF12BEQ52249783-EC01DB55-130D-464D-B843-CC471FB3330DQ52586161-2E25326D-35B7-405D-9B01-0C1B2F7394B5Q53716854-5631EEA0-310F-49DB-A2C8-58A0A1DA41B4Q54747262-8D5A2818-5D22-46E2-9C51-ABC77C81A0B9
P2860
The natural heterogeneity of Trypanosoma cruzi: biological and medical implications.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
The natural heterogeneity of Trypanosoma cruzi: biological and medical implications.
@en
type
label
The natural heterogeneity of Trypanosoma cruzi: biological and medical implications.
@en
prefLabel
The natural heterogeneity of Trypanosoma cruzi: biological and medical implications.
@en
P2860
P356
P1476
The natural heterogeneity of Trypanosoma cruzi: biological and medical implications.
@en
P2093
P2860
P304
P356
10.1002/JCB.240240406
P577
1984-01-01T00:00:00Z